Literature DB >> 12369002

The role of reovirus type 3 infection in an established murine model for biliary atresia.

P O Szavay1, J Leonhardt, G Czech-Schmidt, C Petersen.   

Abstract

AIM OF THE STUDY: Infection of newborn Balb/c-mice with Rhesus rotavirus (RRV) leads to cholestasis and biliary atresia. In this current model, Reovirus Type 3 was investigated to ascertain whether Reovirus Type 3 causes the same or similar hepatobiliary lesions as RRV.
METHODS: Newborn Balb/c-mice were infected with Reovirus Type 3 Dearing and Reovirus Type 3 Abney on the first day of life. Clinical observation followed for a period of at least 10 days. Cholestatic and/or dystrophic mice were prepared and specimens were taken for histological examination.
RESULTS: Infection with RRV showed a 85 % morbidity for biliary atresia as described before. Clinical disease, following an infection with Reovirus T3 Dearing, showed neurological symptoms such as ataxia, and all mice died within 3 weeks. No obstructive or atretic changes of the hepatobiliary ducts could be seen either macroscopically or histomorphologically. 60 % of the mice having been infected with Reovirus T3 Abney showed signs of cholestasis and oily fur syndrome, but almost 15 % recovered from the disease. Although the histological findings did not reveal biliary atresia, inflammation and destruction of bile ducts could be observed.
CONCLUSION: In comparison to the RRV infection in a Balb/c-mice model, where biliary atresia could be induced, infection with Reovirus T3 in this model did not lead to biliary atresia. But Reovirus T3 Abney infection revealed inflammatory signs as described in the literature before. The question as to why different hepatotrophic viruses lead to different changes in the murine hepatobiliary tract has to be investigated in further studies.

Entities:  

Mesh:

Year:  2002        PMID: 12369002     DOI: 10.1055/s-2002-34477

Source DB:  PubMed          Journal:  Eur J Pediatr Surg        ISSN: 0939-7248            Impact factor:   2.191


  15 in total

1.  RRAS: A key regulator and an important prognostic biomarker in biliary atresia.

Authors:  Rui Zhao; Hao Li; Chun Shen; Shan Zheng
Journal:  World J Gastroenterol       Date:  2011-02-14       Impact factor: 5.742

Review 2.  Pathogenesis of biliary atresia: defining biology to understand clinical phenotypes.

Authors:  Akihiro Asai; Alexander Miethke; Jorge A Bezerra
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-05-26       Impact factor: 46.802

Review 3.  Sclerosing and obstructive cholangiopathy in biliary atresia: mechanisms and association with biliary innate immunity.

Authors:  Kenichi Harada
Journal:  Pediatr Surg Int       Date:  2017-10-16       Impact factor: 1.827

4.  The rhesus rotavirus gene encoding VP4 is a major determinant in the pathogenesis of biliary atresia in newborn mice.

Authors:  Wei Wang; Bryan Donnelly; Alexander Bondoc; Sujit K Mohanty; Monica McNeal; Richard Ward; Karol Sestak; Shan Zheng; Greg Tiao
Journal:  J Virol       Date:  2011-06-22       Impact factor: 5.103

5.  Relationship between prognosis of biliary atresia and infection of cytomegalovirus.

Authors:  Chun Shen; Shan Zheng; Wei Wang; Xian-Min Xiao
Journal:  World J Pediatr       Date:  2008-05       Impact factor: 2.764

6.  Interleukin-32 production associated with biliary innate immunity and proinflammatory cytokines contributes to the pathogenesis of cholangitis in biliary atresia.

Authors:  A Okamura; K Harada; M Nio; Y Nakanuma
Journal:  Clin Exp Immunol       Date:  2013-08       Impact factor: 4.330

7.  Obstruction of extrahepatic bile ducts by lymphocytes is regulated by IFN-gamma in experimental biliary atresia.

Authors:  Pranavkumar Shivakumar; Kathleen M Campbell; Gregg E Sabla; Alexander Miethke; Greg Tiao; Monica M McNeal; Richard L Ward; Jorge A Bezerra
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

Review 8.  Screening and outcomes in biliary atresia: summary of a National Institutes of Health workshop.

Authors:  Ronald J Sokol; Ross W Shepherd; Riccardo Superina; Jorge A Bezerra; Patricia Robuck; Jay H Hoofnagle
Journal:  Hepatology       Date:  2007-08       Impact factor: 17.425

9.  A Silver Nanoparticle Method for Ameliorating Biliary Atresia Syndrome in Mice.

Authors:  Ming Fu; Zefeng Lin; Huiting Lin; Yanlu Tong; Hezhen Wang; Hongjiao Chen; Yan Chen; Ruizhong Zhang
Journal:  J Vis Exp       Date:  2018-10-13       Impact factor: 1.355

Review 10.  Biliary innate immunity: function and modulation.

Authors:  Kenichi Harada; Yasuni Nakanuma
Journal:  Mediators Inflamm       Date:  2010-07-27       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.